Down-Regulated Expression of Cytokeratin 18 Promotes Progression of Human Breast Cancer

Abstract

Down-regulation of the luminal CK18 is not rare and a clinically relevant event in breast cancer. This finding has important implications for the use of CK18 as epithelial tumor marker. The correlations with clinical follow-up suggest that CK18 might suppress tumor progression.